All-cause mortality in males with sleep apnoea syndrome: Declining mortality rates with age

European Respiratory Journal

Volumn 25, Issue 3, 2005, Pages 514-520

  Lavie, P ^a   Lavie, L ^a   Herer, P ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

All cause mortality; Body mass index; Males; Sleep apnoea

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE SEVERITY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PATIENT REFERRAL; PRIORITY JOURNAL; RESPIRATORY FAILURE; RISK ASSESSMENT; SEX DIFFERENCE; SLEEP APNEA SYNDROME; STATISTICAL ANALYSIS;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CAUSALITY; COMORBIDITY; FOLLOW-UP STUDIES; HUMANS; ISRAEL; MALE; MIDDLE AGED; OBESITY; REFERENCE VALUES; REGRESSION ANALYSIS; SLEEP APNEA SYNDROMES; SURVIVAL RATE;

EID: 14744283426     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00051504     Document Type: Article

References (43)

1. Lavie L. Obstructive sleep apnea syndrome - an oxidative stress disorder. Sleep Med Rev 2003; 7: 35-51.
2. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002; 165: 934-939.
3. Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004; 27: 123-128.
4. Suzuki T, Nakano H, Maekawa J, et al. Obstructive sleep apnea and carotid-artery intima-media thickness. Sleep 2004; 27: 129-133.
5. Young T, Palta M, Hla KM, Finn L, Morgan B, Skatrud J. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997; 157: 1746-1752.
6. Grote L, Hedner J, Peter JH. Sleep-related breathing disorder is an independent factor for uncontrolled hypertension. J Hypertension 2000; 18: 679-685.
7. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320: 479-482.
8. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea and hypertension in a large community-based study. JAMA 2000; 283: 1829-1836.
9. Peker Y, Kraiczi H, Hedner J, et al. An independent association between obstructive sleep apnea and coronary artery disease. Eur Respir J 1999; 14: 179-184.
10. Mooe T, Rabben T, Wiklund U, et al. Sleep-disordered breathing in men with coronary artery disease. Chest 1996; 109: 659-663.
11. Peled N, Abinader EG, Pillar G, et al. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment. J Am Coll Cardiol 1999; 15: 1744-1749.
12. George CF. Reduction in motor vehicle collisions following treatment of sleep apnea with nasal CPAP. Thorax 2001; 56: 508-512.
13. Masa JF, Rubio M, Findley LJ. Habitually sleepy drivers have a high frequency of automobile crashes associated with respiratory disorders during sleep. Am J Respir Crit Care Med 2000; 162: 1407-1412.
14. He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 1988; 94: 9-14.
15. Lavie P, Herer P, Peled R, et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 1995; 18: 149-157.
16. Marti S, Sampol G, Munoz X, et al. Mortality in severe sleep apnea/hypopnoea syndrome patients: impact of treatment. Eur Respir J 2002; 20: 1511-1518.
17. VanItallie TB. Prevalence of obesity. Endocrinol Metab Clin 1996; 25: 887-905.
18. Calle EE, Thun MJ, Petralli JM, et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-1105.
19. Dyer AR, Stamler J, Garside DB, Greenland P. Long-term consequences of body mass index for cardiovascular mortality: the Chicago Heart Association Detection Project in Industry study. Ann Epidemiol 2004; 14: 101-108.
20. Kiely JL, McNicholas WT. Cardiovascular risk factors in patients with obstructive sleep apnea syndrome. Eur Respir J 2000; 16: 128-133.
21. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-1384.
22. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002; 166: 159-165.
23. Partinen M, Guilleminault C. Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest 1990; 97: 27-32.
24. Fisher D, Pillar G, Malhotra A, Peled N, Lavie P. Long-term follow-up of untreated patients with sleep apnoea syndrome. Respir Med 2002; 96: 337-343.
25. Lavie P. Treatment of sleep apnea: unmet needs. Chest 1999; 116: 1501-1503.
26. Veale D, Chailleux E, Hoorelbeke-Ramon A, et al. Mortality of sleep apnea patients treated by nasal continuous positive airway pressure registered in the ANTADIR observatory. Eur Respir J 2000; 15: 326-331.
27. Chaouat A. Mortality in treated sleep apnea syndrome. Rev Neurol (Paris) 2003; 159: Suppl. 11, 6S95-6S97.
28. Sforza E, Addati G, Cirignotta. F, Lugaresi E. Natural evolution of sleep apnoea syndrome: a five year longitudinal study. Eur Respir J 1994; 7: 1765-1770.
29. Svanborg E, Larsson H. Natural evolution of obstructive sleep apnoea syndrome. Sleep 1993; 16: S124-S125.
30. Rosenthal L, Rohers T, Roth T. Natural evolution of sleep apnea: a two year follow-up. In: Kuna S, Suratt P, Remmers J, eds. Sleep and respiration in aging adults. New York, Elsevier, 1991; pp. 348-353.
31. Pendelbury ST, Pepin JL, Veale D, Levy P. Natural evolution of sleep apnoea syndrome: significant progression over a mean of 17 months. Thorax 1997; 52: 872-878.
32. Phoha RL, Dickel MJ, Mosko SS. Preliminary longitudinal assessment of sleep in the elderly. Sleep 1990; 13: 425-429.
33. Bliwise D, Carskadon M, Carey E, Dement W. Longitudinal development of sleep related respiratory disturbance in adult humans. J Gerontol 1984; 39: 290-293.
34. Ancoli-Israel S, Kripke DF, Klauber MR, et al. Natural history of sleep disordered breathing in community dwelling elderly. Sleep 1993; 16: 525-529.
35. Lindberg E, Janson C, Svardsudd K, Gislason T, Hetta J, Boman G. Increased mortality among sleepy snorers: a prospective population based study. Thorax 1998; 3: 631-637.
36. Ancoli-Israel S, Kripke DF, Klauber MR, et al. Morbidity, mortality and sleep-disordered breathing in community dwelling elderly. Sleep 1996; 19: 277-282.
37. Ancoli-Israel S, DuHamel ER, Stepnowsky C, Engler R, Cohen-Zion M, Marler M. The relationship between congestive heart failure, sleep apnea, and mortality in older men. Chest 2003; 124: 1400-1405.
38. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163: 19-25.
39. Ip MS, Tse HF, Lam B, Tsang KW, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004; 169: 348-353.
40. Kato M, Roberts-Thomson P, Phillips BG, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000; 102: 2607-2610.
41. Kraiczi H, Caidahl K, Samuelsson A, Peker Y, Hedner J. Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest 2001; 119: 1085-1091.
42. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-2678.
43. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23: 168-175.